Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 4 publications
A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non-small-cell Lung Cancer: SWOG 1206 (8811).
Journal: Clinical lung cancer
Published: November 21, 2020
STRN-ALK, A Novel In-Frame Fusion With Response to Alectinib.
Journal: JTO clinical and research reports
Published: October 22, 2020
Pharmacokinetics, safety, and efficacy of APF530 (extended-release granisetron) in patients receiving moderately or highly emetogenic chemotherapy: results of two Phase II trials.
Journal: Cancer management and research
Published: April 03, 2015
XL647--a multitargeted tyrosine kinase inhibitor: results of a phase II study in subjects with non-small cell lung cancer who have progressed after responding to treatment with either gefitinib or erlotinib.
Journal: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer
Published: October 21, 2011
Showing 1-4 of 4
Last Updated: 09/26/2026